Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications

Bibliography

• Nozaki O. Steroid analysis for medical diagnosis. J Chromatogr A 2001;935(1-2):267-78
   PubMed Web of Science ®Google Scholar
• Chabbert-Buffet N, Ouzounian S, Kairis AP, Bouchard P. Contraceptive applications of progesterone receptor modulators. Eur J Contracept Reprod Health Care 2008;13(3):222-30
   PubMed Web of Science ®Google Scholar
• Shahidi NT. A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther 2001;23(9):1355-90
   PubMed Web of Science ®Google Scholar
• Dinan L, Harmatha J, Lafont R. Chromatographic procedures for the isolation of plant steroids. J Chromatogr A 2001;935(1-2):105-23
   PubMed Web of Science ®Google Scholar
• Vico P, Cauet G, Rose K, et al. Dehydroepiandrosterone (DHEA) metabolism in Saccharomyces cerevisiae expressing mammalian steroid hydroxylase CYP7B: Ayr1p and Fox2p display 17beta-hydroxysteroid dehydrogenase activity. Yeast 2002;19(10):873-86
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 2006;8(1):E101-111
   PubMed Web of Science ®Google Scholar
• Turgeon D, Carrier JS, Lévesque E, et al. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 2001;142(2):778-87
   PubMed Web of Science ®Google Scholar
• Strott CA. Sulfonation and molecular action. Endocr Rev 2002;23(5):703-32
   PubMed Web of Science ®Google Scholar
• Ball P, Knuppen R. Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol Suppl (Copenh) 1980;232:1-127
   PubMedGoogle Scholar
• Yue W, Santen RJ, Wang JP, et al. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 2003;86(3-5):477-86
   PubMed Web of Science ®Google Scholar
• You L. Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes. Chem Biol Interact 2004;147(3):233-46
   PubMed Web of Science ®Google Scholar
• Nebert DW, Russell DW. Clinical importance of the cytochromes P450. Lancet 2002;360(9340):1155-62
   PubMed Web of Science ®Google Scholar
• Witt BR, Thorneycroft IH. Reproductive steroid hormones: generation, degradation, reception, and action. Clin Obstet Gynecol 1990;33(3):563-75
   PubMed Web of Science ®Google Scholar
• Tsuchiya Y, Nakajima M, Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 2005;227(2):115-24
   PubMed Web of Science ®Google Scholar
• Balogh A, Gessinger S, Svarovsky U, et al. Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans? Eur J Clin Pharmacol 1998;54(9-10):729-34
   PubMed Web of Science ®Google Scholar
• Iyer M, Reschly EJ, Krasowski MD. Functional evolution of the pregnane X receptor. Expert Opin Drug Metab Toxicol 2006;2(3):381-97
   PubMed Web of Science ®Google Scholar
• Lin JH. CYP induction-mediated drug interactions: in vitro assessment and clinical implications. Pharm Res 2006;23(6):1089-116
   PubMed Web of Science ®Google Scholar
• Luoma PV. Cytochrome P450 and gene activation–from pharmacology to cholesterol elimination and regression of atherosclerosis. Eur J Clin Pharmacol 2008;64(9):841-50
   PubMed Web of Science ®Google Scholar
• Omura T. Mitochondrial P450s. Chem Biol Interact. 2006;163(1-2):86-93
   Google Scholar
• Nishimura M, Yaguti H, Yoshitsugu H, et al. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 2003;123(5):369-75
   PubMed Web of Science ®Google Scholar
• Ryner LC, Swain A. Sex in the ‘90s. Cell 1995;81(4):483-93
   PubMed Web of Science ®Google Scholar
• Lee AJ, Cai MX, Thomas PE, et al. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 2003;144(8):3382-98
   PubMed Web of Science ®Google Scholar
• Niwa T, Yabusaki Y, Honma K, et al. Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones. Xenobiotica 1998;28(6):539-47
   PubMed Web of Science ®Google Scholar
• Doostzadeh J, Urban P, Pompon D, Morfin R. Pregnenolone-7 beta-hydroxylating activities of yeast-expressed mouse cytochrome P450-1A1 and mouse-tissue microsomes. Eur J Biochem 1996;242(3):641-7
   PubMedGoogle Scholar
• Doostzadeh J, Flinois JP, Beaune P, Morfin R. Pregnenolone-7beta-hydroxylating activity of human cytochrome P450-1A1. J Steroid Biochem Mol Biol 1997;60(1-2):147-52
   PubMed Web of Science ®Google Scholar
• Waxman DJ. Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochem Pharmacol 1988;37(1):71-84
   PubMed Web of Science ®Google Scholar
• Shimada T, Hayes CL, Yamazaki H, et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 1996;56(13):2979-84
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Shaw PM, Guengerich FP, Shimada T. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Chem Res Toxicol 1998;11(6):659-65
   PubMed Web of Science ®Google Scholar
• Liehr JG. Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 2000;21(1):40-54
   PubMed Web of Science ®Google Scholar
• Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000;60(2):235-7
   PubMed Web of Science ®Google Scholar
• Shimada T, Yamazaki H, Mimura M, et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270(1):414-23
   PubMed Web of Science ®Google Scholar
• Ekins S, Vandenbranden M, Ring BJ, et al. Further characterization of the expression in liver and catalytic activity of CYP2B6. J Pharmacol Exp Ther 1998;286(3):1253-9
   PubMed Web of Science ®Google Scholar
• Imaoka S, Yamada T, Hiroi T, et al. Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. Biochem Pharmacol 1996;51(8):1041-50
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Shimada T. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch Biochem Biophys 1997;346(1):161-9
   PubMed Web of Science ®Google Scholar
• Gentile DM, Verhoeven CH, Shimada T, Back DJ. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel. J Pharmacol Exp Ther 1998;287(3):975-82
   PubMed Web of Science ®Google Scholar
• Korhonen T, Turpeinen M, Tolonen A, et al. Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone. J Steroid Biochem Mol Biol 2008;110(1-2):56-66
   PubMed Web of Science ®Google Scholar
• Delaforge M, Pruvost A, Perrin L, André F. Cytochrome P450-mediated oxidation of glucuronide derivatives: example of estradiol-17beta-glucuronide oxidation to 2-hydroxy-estradiol-17beta-glucuronide by CYP 2C8. Drug Metab Dispos 2005;33(3):466-73
   PubMed Web of Science ®Google Scholar
• Domanski TL, He YA, Harlow GR, Halpert JR. Dual role of human cytochrome P450 3A4 residue Phe-304 in substrate specificity and cooperativity. J Pharmacol Exp Ther 2000;293(2):585-51
   PubMed Web of Science ®Google Scholar
• Choi MH, Skipper PL, Wishnok JS, Tannenbaum SR. Characterization of testosterone 11 beta-hydroxylation catalyzed by human liver microsomal cytochromes P450. Drug Metab Dispos 2005;33(6):714-8
   PubMed Web of Science ®Google Scholar
• Lee AJ, Kosh JW, Conney AH, Zhu BT. Characterization of the NADPH-dependent metabolism of 17beta-estradiol to multiple metabolites by human liver microsomes and selectively expressed human cytochrome P450 3A4 and 3A5. J Pharmacol Exp Ther 2001;298(2):420-32
   PubMed Web of Science ®Google Scholar
• Aoyama T, Yamano S, Waxman DJ, et al. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J Biol Chem 1989;264(18):10388-95
   PubMed Web of Science ®Google Scholar
• Lee AJ, Cai MX, Thomas PE, et al. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology 2003;144(8):3382-98
   PubMed Web of Science ®Google Scholar
• Ohmori S, Nakasa H, Asanome K, et al. Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells. Biochim Biophys Acta 1998;1380(3):297-304
   PubMed Web of Science ®Google Scholar
• Kitada M, Kamataki T, Itahashi K, et al. P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16 alpha-hydroxylase of dehydroepiandrosterone 3-sulfate. J Biol Chem 1987;262(28):13534-7
   PubMed Web of Science ®Google Scholar
• Zhang JW, Liu Y, Zhao JY, et al. Metabolic profiling and cytochrome P450 reaction phenotyping of medroxyprogesterone acetate. Drug Metab Dispos 2008;36(11):2292-8
   PubMed Web of Science ®Google Scholar
• McCamish M, Rossi E, De Pascale A, et al. The in vitro metabolism of medroxyprogesterone acetate. In: Frigerio A, McCamish M, editors, Recent developments in mass spectrometry in biochemistry and medicine; 1979. p. 243-51
   Google Scholar
• Siddique YH, Ara G, Beg T, Afzal M. Genotoxic potential of medroxyprogesterone acetate in cultured human peripheral blood lymphocytes. Life Sci 2006;80(3):212-8
   PubMed Web of Science ®Google Scholar
• Harlow GR, Halpert JR. Alanine-scanning mutagenesis of a putative substrate recognition site in human cytochrome P450 3A4. Role of residues 210 and 211 in flavonoid activation and substrate specificity. J Biol Chem 1997;272(9):5396-402
   PubMed Web of Science ®Google Scholar
• Rendic S, Nolteernsting E, Schänzer W. Metabolism of anabolic steroids by recombinant human cytochrome P450 enzymes. Gas chromatographic-mass spectrometric determination of metabolites. J Chromatogr B Biomed Sci Appl 1999;735(1):73-83
   PubMed Web of Science ®Google Scholar
• Wang YH, Han KL, Yang SL, Yang L. Structural determinants of steroids for cytochrome P450 3A4-mediated metabolism. J Mor Struc Theochem 2004;710:215-21
   Web of Science ®Google Scholar
• Mesiano S, Coulter CL, Jaffe RB. Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17 alpha-hydroxylase/17, 20-lyase, and 3 beta-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J Clin Endocrinol Metab 1993;77(5):1184-9
   PubMed Web of Science ®Google Scholar
• Stone D, Hechter O. Studies on ACTH action in perfused bovine adrenals: the site of action of ACTH in corticosteroidogenesis. Arch Biochem 1954;51(2):457-69
   PubMed Web of Science ®Google Scholar
• Titus MA, Schell MJ, Lih FB, et al. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res 2005;11(13):4653-7
   PubMed Web of Science ®Google Scholar
• Yap TA, Carden CP, Attard G, de Bono JS. Targeting CYP17: established and novel approaches in prostate cancer. Curr Opin Pharmacol 2008;8(4):449-57
   PubMed Web of Science ®Google Scholar
• Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004;25(6):947-70
   PubMed Web of Science ®Google Scholar
• Brueggemeier RW, Hackett JC, Diaz-Cruz ES. Aromatase inhibitors in the treatment of breast cancer. Endocr Rev 2005;26(3):331-45
   PubMed Web of Science ®Google Scholar
• Garcia-Segura LM. Aromatase in the brain: not just for reproduction anymore. J Neuroendocrinol 2008;20(6):705-12
   PubMed Web of Science ®Google Scholar
• Gomes LG, Huang N, Agrawal V, et al. Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. J Clin Endocrinol Metab 2009;94(1):89-95
   PubMed Web of Science ®Google Scholar
• Pichard L, Fabre I, Daujat M, et al. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes. Mol Pharmacol 1992;41(6):1047-55
   PubMed Web of Science ®Google Scholar
• Pichard L, Fabre I, Fabre G, et al. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos 1990;18(5):595-606
   PubMed Web of Science ®Google Scholar
• Zhang JW, Liu Y, Li W, et al. Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes. Eur J Clin Pharmacol 2006;62(7):497-502
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Mimura N, Fujii H, et al. Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate. Clin Cancer Res 2000;6(8):3297-303
   PubMed Web of Science ®Google Scholar
• Dubey RK, Jackson EK, Gillespie DG, et al. Medroxyprogesterone abrogates the inhibitory effects of estradiol on vascular smooth muscle cells by preventing estradiol metabolism. Hypertension 2008;51(4):1197-202
   PubMed Web of Science ®Google Scholar
• Laine K, Yasar U, Widén J, Tybring G. A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19 and 3A4 activities in human liver microsomes. Pharmacol Toxicol 2003;93(2):77-81
   PubMedGoogle Scholar
• Zhou S, Gao Y, Jiang W, et al. Interactions of herbs with cytochrome P450. Drug Metab Rev 2003;35(1):35-98
   PubMed Web of Science ®Google Scholar
• Chang TK, Chen J, Benetton SA. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1. Drug Metab Dispos 2002;30(4):378-84
   PubMed Web of Science ®Google Scholar
• Henderson GL, Harkey MR, Gershwin ME, et al. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 1999;65(15):PL209-14
   PubMed Web of Science ®Google Scholar
• Liu Y, Li W, Li P, et al. The inhibitory effect of intestinal bacterial metabolite of ginsenosides on CYP3A activity. Biol Pharm Bull 2004;27(10):1555-60
   PubMed Web of Science ®Google Scholar
• Liu Y, Ma H, Zhang JW, et al. Influence of ginsenoside Rh1 and F1 on human cytochrome p450 enzymes. Planta Med 2006;72(2):126-31
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang JW, Li W, et al. Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes. Toxicol Sci 2006;91(2):356-64
   PubMed Web of Science ®Google Scholar
• Polasek TM, Miners JO. In vitro approaches to investigate mechanism-based inactivation of CYP enzymes. Expert Opin Drug Metab Toxicol 2007;3(3):321-9
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chem Res Toxicol 1990;3(4):363-71
   PubMed Web of Science ®Google Scholar
• Lin HL, Kent UM, Hollenberg PF. Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein. J Pharmacol Exp Ther 2002;301(1):160-7
   PubMed Web of Science ®Google Scholar
• He K, Woolf TF, Hollenberg PF. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486). J Pharmacol Exp Ther 1999;288(2):791-7
   PubMed Web of Science ®Google Scholar
• Hollenberg PF, Lin HL, Zhang H. Metabolic activation of mifepristone (RU486) by mammalian P450s and the mechanism-based inactivation of human CYP2B6. J Pharmacol Exp Ther 2009;329(1):26-37
   PubMed Web of Science ®Google Scholar
• Tang W, Stearns RA. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions. Curr Drug Metab 2001;2(2):185-98
   PubMed Web of Science ®Google Scholar
• Maenpaa J, Hall SD, Ring BJ, et al. Human cytochrome P450 3A(CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by naphthoflavone, terfenadine and testosterone. Pharmacogenetics 1998;8:137-55
   PubMedGoogle Scholar
• Schrag ML, Wienkers LC. Triazolam substrate inhibition: evidence of competition for heme-bound reactive oxygen within the CYP3A4 active site. Drug Metab Dispos 2001;29:70-5
   PubMed Web of Science ®Google Scholar
• Nakamura H, Nakasa H, Ishii I, et al. Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes. Drug Metab Dispos 2002;30(5):534-40
   PubMed Web of Science ®Google Scholar
• Nakamura H, Torimoto N, Ishii I, et al. CYP3A4 and CYP3A7-mediated carbamazepine 10,11-epoxidation are activated by differential endogenous steroids. Drug Metab Dispos 2003;31(4):432-8
   PubMed Web of Science ®Google Scholar
• Torimoto N, Ishii I, Hata M, et al. Direct interaction between substrates and endogenous steroids in the active site may change the activity of cytochrome P450 3A4. Biochemistry 2003;42(51):15068-77
   PubMed Web of Science ®Google Scholar
• Morfin R. Involvement of steroids and cytochromes P(450) species in the triggering of immune defenses. J Steroid Biochem Mol Biol 2002;80(3):273-90
   PubMed Web of Science ®Google Scholar
• Kim SB, Chalbot S, Pompon D, et al. The human cytochrome P4507B1: catalytic activity studies. J Steroid Biochem Mol Biol 2004;92(5):383-9
   PubMed Web of Science ®Google Scholar